CA3171027A1 - Systems and methods for non-invasive determination of covid-19 coronavirus infection - Google Patents
Systems and methods for non-invasive determination of covid-19 coronavirus infection Download PDFInfo
- Publication number
- CA3171027A1 CA3171027A1 CA3171027A CA3171027A CA3171027A1 CA 3171027 A1 CA3171027 A1 CA 3171027A1 CA 3171027 A CA3171027 A CA 3171027A CA 3171027 A CA3171027 A CA 3171027A CA 3171027 A1 CA3171027 A1 CA 3171027A1
- Authority
- CA
- Canada
- Prior art keywords
- membrane
- virus
- sampler
- collected media
- individuals
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 669
- 208000025721 COVID-19 Diseases 0.000 title claims 45
- 208000001528 Coronaviridae Infections Diseases 0.000 title description 2
- 239000012528 membrane Substances 0.000 claims abstract description 691
- 241000700605 Viruses Species 0.000 claims abstract description 600
- 238000001514 detection method Methods 0.000 claims abstract description 175
- 239000000443 aerosol Substances 0.000 claims abstract description 136
- 150000001875 compounds Chemical class 0.000 claims abstract description 131
- 238000004458 analytical method Methods 0.000 claims abstract description 4
- 238000004422 calculation algorithm Methods 0.000 claims description 297
- 230000005670 electromagnetic radiation Effects 0.000 claims description 249
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 152
- 102000004169 proteins and genes Human genes 0.000 claims description 137
- 108090000623 proteins and genes Proteins 0.000 claims description 137
- 150000004677 hydrates Chemical class 0.000 claims description 136
- 238000000862 absorption spectrum Methods 0.000 claims description 121
- 238000010801 machine learning Methods 0.000 claims description 121
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 claims description 114
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 claims description 114
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 108
- 102000015696 Interleukins Human genes 0.000 claims description 90
- 108010063738 Interleukins Proteins 0.000 claims description 90
- 102000004889 Interleukin-6 Human genes 0.000 claims description 88
- 108090001005 Interleukin-6 Proteins 0.000 claims description 88
- 229940100601 interleukin-6 Drugs 0.000 claims description 88
- 238000003909 pattern recognition Methods 0.000 claims description 86
- 102000010789 Interleukin-2 Receptors Human genes 0.000 claims description 85
- 108010038453 Interleukin-2 Receptors Proteins 0.000 claims description 85
- 239000000463 material Substances 0.000 claims description 85
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 claims description 76
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 76
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 76
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 claims description 76
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 claims description 76
- 239000001569 carbon dioxide Substances 0.000 claims description 76
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 76
- ZAJNGDIORYACQU-UHFFFAOYSA-N decan-2-one Chemical compound CCCCCCCCC(C)=O ZAJNGDIORYACQU-UHFFFAOYSA-N 0.000 claims description 76
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 claims description 76
- FXHGMKSSBGDXIY-UHFFFAOYSA-N heptanal Chemical compound CCCCCCC=O FXHGMKSSBGDXIY-UHFFFAOYSA-N 0.000 claims description 76
- JARKCYVAAOWBJS-UHFFFAOYSA-N hexanal Chemical compound CCCCCC=O JARKCYVAAOWBJS-UHFFFAOYSA-N 0.000 claims description 76
- VKCYHJWLYTUGCC-UHFFFAOYSA-N nonan-2-one Chemical compound CCCCCCCC(C)=O VKCYHJWLYTUGCC-UHFFFAOYSA-N 0.000 claims description 76
- KYWIYKKSMDLRDC-UHFFFAOYSA-N undecan-2-one Chemical compound CCCCCCCCCC(C)=O KYWIYKKSMDLRDC-UHFFFAOYSA-N 0.000 claims description 76
- CRBJBYGJVIBWIY-UHFFFAOYSA-N 2-isopropylphenol Chemical compound CC(C)C1=CC=CC=C1O CRBJBYGJVIBWIY-UHFFFAOYSA-N 0.000 claims description 74
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 71
- WQOXQRCZOLPYPM-UHFFFAOYSA-N dimethyl disulfide Chemical compound CSSC WQOXQRCZOLPYPM-UHFFFAOYSA-N 0.000 claims description 70
- 238000000513 principal component analysis Methods 0.000 claims description 67
- YWHLKYXPLRWGSE-UHFFFAOYSA-N Dimethyl trisulfide Chemical compound CSSSC YWHLKYXPLRWGSE-UHFFFAOYSA-N 0.000 claims description 66
- 210000004027 cell Anatomy 0.000 claims description 63
- 239000002775 capsule Substances 0.000 claims description 54
- 238000012549 training Methods 0.000 claims description 51
- 230000001133 acceleration Effects 0.000 claims description 50
- 238000012545 processing Methods 0.000 claims description 50
- 108010002586 Interleukin-7 Proteins 0.000 claims description 46
- 102000014962 Monocyte Chemoattractant Proteins Human genes 0.000 claims description 46
- 108010064136 Monocyte Chemoattractant Proteins Proteins 0.000 claims description 46
- 206010054094 Tumour necrosis Diseases 0.000 claims description 46
- 108010067390 Viral Proteins Proteins 0.000 claims description 46
- 230000001413 cellular effect Effects 0.000 claims description 46
- 230000001939 inductive effect Effects 0.000 claims description 46
- 230000002757 inflammatory effect Effects 0.000 claims description 46
- 210000002540 macrophage Anatomy 0.000 claims description 46
- 230000004936 stimulating effect Effects 0.000 claims description 46
- -1 aromatic alcohols Chemical class 0.000 claims description 45
- 102000004127 Cytokines Human genes 0.000 claims description 44
- 108090000695 Cytokines Proteins 0.000 claims description 44
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 44
- 229910052710 silicon Inorganic materials 0.000 claims description 44
- 238000012360 testing method Methods 0.000 claims description 44
- 230000011664 signaling Effects 0.000 claims description 43
- 239000010703 silicon Substances 0.000 claims description 43
- 239000006096 absorbing agent Substances 0.000 claims description 42
- 150000002894 organic compounds Chemical class 0.000 claims description 41
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 claims description 38
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 claims description 38
- 229910021529 ammonia Inorganic materials 0.000 claims description 38
- 150000002576 ketones Chemical class 0.000 claims description 38
- 239000000203 mixture Substances 0.000 claims description 38
- 239000001272 nitrous oxide Substances 0.000 claims description 38
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 claims description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 38
- VEAFKIYNHVBNIP-UHFFFAOYSA-N 1,3-Diphenylpropane Chemical compound C=1C=CC=CC=1CCCC1=CC=CC=C1 VEAFKIYNHVBNIP-UHFFFAOYSA-N 0.000 claims description 37
- VCHOFVSNWYPAEF-UHFFFAOYSA-N 1-(3-acetylphenyl)ethanone Chemical compound CC(=O)C1=CC=CC(C(C)=O)=C1 VCHOFVSNWYPAEF-UHFFFAOYSA-N 0.000 claims description 37
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 claims description 37
- 239000005431 greenhouse gas Substances 0.000 claims description 37
- YIWUKEYIRIRTPP-UHFFFAOYSA-N 2-ethylhexan-1-ol Chemical compound CCCCC(CC)CO YIWUKEYIRIRTPP-UHFFFAOYSA-N 0.000 claims description 35
- 150000001299 aldehydes Chemical class 0.000 claims description 35
- 150000002484 inorganic compounds Chemical class 0.000 claims description 35
- 229910010272 inorganic material Inorganic materials 0.000 claims description 35
- 208000024891 symptom Diseases 0.000 claims description 35
- 206010037660 Pyrexia Diseases 0.000 claims description 33
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 33
- 230000036772 blood pressure Effects 0.000 claims description 32
- 230000036760 body temperature Effects 0.000 claims description 32
- 230000036387 respiratory rate Effects 0.000 claims description 32
- 210000004243 sweat Anatomy 0.000 claims description 32
- 230000003287 optical effect Effects 0.000 claims description 31
- NMRPBPVERJPACX-UHFFFAOYSA-N (3S)-octan-3-ol Natural products CCCCCC(O)CC NMRPBPVERJPACX-UHFFFAOYSA-N 0.000 claims description 30
- WOFPPJOZXUTRAU-UHFFFAOYSA-N 2-Ethyl-1-hexanol Natural products CCCCC(O)CCC WOFPPJOZXUTRAU-UHFFFAOYSA-N 0.000 claims description 30
- 238000004891 communication Methods 0.000 claims description 27
- 239000007789 gas Substances 0.000 claims description 25
- 208000002979 Influenza in Birds Diseases 0.000 claims description 22
- 206010064097 avian influenza Diseases 0.000 claims description 22
- 230000005611 electricity Effects 0.000 claims description 22
- 206010022000 influenza Diseases 0.000 claims description 22
- CTMHWPIWNRWQEG-UHFFFAOYSA-N trans cyclohexenyl ester Natural products CC1=CCCCC1 CTMHWPIWNRWQEG-UHFFFAOYSA-N 0.000 claims description 22
- 230000009466 transformation Effects 0.000 claims description 22
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 21
- 229920000877 Melamine resin Polymers 0.000 claims description 21
- 239000006260 foam Substances 0.000 claims description 21
- 229910021389 graphene Inorganic materials 0.000 claims description 21
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 claims description 21
- 230000005855 radiation Effects 0.000 claims description 21
- 238000005070 sampling Methods 0.000 claims description 21
- 230000001755 vocal effect Effects 0.000 claims description 21
- 238000013459 approach Methods 0.000 claims description 18
- 238000000605 extraction Methods 0.000 claims description 18
- 239000003000 extruded plastic Substances 0.000 claims description 18
- 239000013598 vector Substances 0.000 claims description 18
- 239000003814 drug Substances 0.000 claims description 16
- 210000004379 membrane Anatomy 0.000 claims 522
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims 28
- 230000009977 dual effect Effects 0.000 claims 12
- 238000010521 absorption reaction Methods 0.000 claims 11
- 238000007789 sealing Methods 0.000 claims 10
- 239000002699 waste material Substances 0.000 claims 10
- 102000005962 receptors Human genes 0.000 claims 7
- 108020003175 receptors Proteins 0.000 claims 7
- 229920004943 Delrin® Polymers 0.000 claims 6
- 229930040373 Paraformaldehyde Natural products 0.000 claims 6
- 230000008878 coupling Effects 0.000 claims 6
- 238000010168 coupling process Methods 0.000 claims 6
- 238000005859 coupling reaction Methods 0.000 claims 6
- 229920006324 polyoxymethylene Polymers 0.000 claims 6
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 claims 5
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims 4
- 239000004810 polytetrafluoroethylene Substances 0.000 claims 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 3
- JWQKMEKSFPNAIB-UHFFFAOYSA-N 1-methyl-5-prop-1-en-2-ylcyclohexene Chemical compound CC(=C)C1CCC=C(C)C1 JWQKMEKSFPNAIB-UHFFFAOYSA-N 0.000 claims 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 claims 2
- 239000004809 Teflon Substances 0.000 claims 2
- 229920006362 Teflon® Polymers 0.000 claims 2
- LZDKZFUFMNSQCJ-UHFFFAOYSA-N 1,2-diethoxyethane Chemical compound CCOCCOCC LZDKZFUFMNSQCJ-UHFFFAOYSA-N 0.000 claims 1
- 239000001294 propane Substances 0.000 claims 1
- 238000003012 network analysis Methods 0.000 description 14
- 241000711573 Coronaviridae Species 0.000 description 8
- 229920000139 polyethylene terephthalate Polymers 0.000 description 5
- 239000005020 polyethylene terephthalate Substances 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 2
- 241000127282 Middle East respiratory syndrome-related coronavirus Species 0.000 description 2
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 206010041232 sneezing Diseases 0.000 description 2
- 102100034613 Annexin A2 Human genes 0.000 description 1
- 108090000668 Annexin A2 Proteins 0.000 description 1
- 241000282836 Camelus dromedarius Species 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000282375 Herpestidae Species 0.000 description 1
- 208000025370 Middle East respiratory syndrome Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 238000011898 label-free detection Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 238000010223 real-time analysis Methods 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/55—Specular reflectivity
- G01N21/552—Attenuated total reflection
- G01N21/553—Attenuated total reflection and using surface plasmons
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
- G01N21/3581—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light using far infrared light; using Terahertz radiation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/497—Physical analysis of biological material of gaseous biological material, e.g. breath
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N20/00—Machine learning
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N2021/775—Indicator and selective membrane
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/12—Circuits of general importance; Signal processing
- G01N2201/129—Using chemometrical methods
- G01N2201/1296—Using chemometrical methods using neural networks
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N3/00—Computing arrangements based on biological models
- G06N3/02—Neural networks
- G06N3/08—Learning methods
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Software Systems (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Theoretical Computer Science (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Medical Informatics (AREA)
- Evolutionary Computation (AREA)
- Computing Systems (AREA)
- General Engineering & Computer Science (AREA)
- Mathematical Physics (AREA)
- Data Mining & Analysis (AREA)
- Artificial Intelligence (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (41)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062992627P | 2020-03-20 | 2020-03-20 | |
| US62/992,627 | 2020-03-20 | ||
| US202063000077P | 2020-03-26 | 2020-03-26 | |
| US63/000,077 | 2020-03-26 | ||
| US202063002404P | 2020-03-31 | 2020-03-31 | |
| IL273709A IL273709A (en) | 2020-03-31 | 2020-03-31 | A system and method for non-invasively detection of coronoavirus (covid-19) |
| IL273709 | 2020-03-31 | ||
| US63/002,404 | 2020-03-31 | ||
| US202063012682P | 2020-04-20 | 2020-04-20 | |
| US202063012672P | 2020-04-20 | 2020-04-20 | |
| US63/012,682 | 2020-04-20 | ||
| US63/012,672 | 2020-04-20 | ||
| US202063015723P | 2020-04-27 | 2020-04-27 | |
| US202063015714P | 2020-04-27 | 2020-04-27 | |
| US63/015,723 | 2020-04-27 | ||
| US63/015,714 | 2020-04-27 | ||
| US202063032735P | 2020-06-01 | 2020-06-01 | |
| US202063032732P | 2020-06-01 | 2020-06-01 | |
| US63/032,735 | 2020-06-01 | ||
| US63/032,732 | 2020-06-01 | ||
| US202063038921P | 2020-06-15 | 2020-06-15 | |
| US202063038920P | 2020-06-15 | 2020-06-15 | |
| US63/038,920 | 2020-06-15 | ||
| US63/038,921 | 2020-06-15 | ||
| US202063051398P | 2020-07-14 | 2020-07-14 | |
| US202063051399P | 2020-07-14 | 2020-07-14 | |
| US63/051,398 | 2020-07-14 | ||
| US63/051,399 | 2020-07-14 | ||
| US202063057318P | 2020-07-28 | 2020-07-28 | |
| US202063057319P | 2020-07-28 | 2020-07-28 | |
| US63/057,318 | 2020-07-28 | ||
| US63/057,319 | 2020-07-28 | ||
| US202063075316P | 2020-09-08 | 2020-09-08 | |
| US202063075324P | 2020-09-08 | 2020-09-08 | |
| US63/075,316 | 2020-09-08 | ||
| US63/075,324 | 2020-09-08 | ||
| US202063111089P | 2020-11-09 | 2020-11-09 | |
| US202063111091P | 2020-11-09 | 2020-11-09 | |
| US63/111,091 | 2020-11-09 | ||
| US63/111,089 | 2020-11-09 | ||
| PCT/IB2021/052327 WO2021186412A1 (en) | 2020-03-20 | 2021-03-19 | Systems and methods for non-invasive determination of covid-19 coronavirus infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3171027A1 true CA3171027A1 (en) | 2021-09-23 |
Family
ID=77770745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3171027A Pending CA3171027A1 (en) | 2020-03-20 | 2021-03-19 | Systems and methods for non-invasive determination of covid-19 coronavirus infection |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP4121760A4 (de) |
| CA (1) | CA3171027A1 (de) |
| WO (1) | WO2021186412A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023118947A1 (en) * | 2021-12-25 | 2023-06-29 | Ai Innobio Limited | System and method for classifying fluid substance with absorption spectroscopy |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100086750A1 (en) * | 2008-10-08 | 2010-04-08 | Lucent Technologies Inc. | Conductive polymer metamaterials |
| KR20170036890A (ko) * | 2015-09-23 | 2017-04-04 | 한국과학기술연구원 | 테라헤르츠 전자기파를 이용한 고민감성 및 고선택성 조류인플루엔자 바이러스 측정방법 및 이에 사용되는 디바이스 |
| JP6951854B2 (ja) * | 2017-03-29 | 2021-10-20 | 株式会社日立ハイテク | 容器搬送機構およびこれを備えた分析装置 |
| MX2020000862A (es) * | 2017-07-23 | 2020-08-20 | Terahertz Group Ltd | Un sistema y metodo para determinar las propiedades del huevo de manera no invasiva. |
| CN108211807B (zh) * | 2018-01-15 | 2021-11-23 | 浙江汇甬新材料有限公司 | 一种分子筛膜的处理方法 |
| CN110487751A (zh) * | 2019-09-03 | 2019-11-22 | 山东师范大学 | 石墨烯增敏ito超材料u型spr传感器 |
| WO2021191768A2 (en) * | 2020-03-24 | 2021-09-30 | Ram Thz Solutions Pte. Ltd. | Microelectronic sensors for detection of analytes, devices and methods using the same |
-
2021
- 2021-03-19 CA CA3171027A patent/CA3171027A1/en active Pending
- 2021-03-19 EP EP21771884.0A patent/EP4121760A4/de active Pending
- 2021-03-19 WO PCT/IB2021/052327 patent/WO2021186412A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| EP4121760A4 (de) | 2024-03-20 |
| WO2021186412A1 (en) | 2021-09-23 |
| EP4121760A1 (de) | 2023-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11510592B2 (en) | Systems and methods for non-invasive determination of COVID-19 coronavirus infection | |
| Pal et al. | Pay attention to the cough: Early diagnosis of COVID-19 using interpretable symptoms embeddings with cough sound signal processing | |
| Santos et al. | Spectroscopy with computational analysis in virological studies: A decade (2006–2016) | |
| US11172846B2 (en) | Gas sampling device | |
| CN110353685B (zh) | 用于处理患者声音的方法与装置 | |
| Zulfiqar et al. | Hyperspectral imaging for bloodstain identification | |
| van Mastrigt et al. | Exhaled breath profiling using broadband quantum cascade laser-based spectroscopy in healthy children and children with asthma and cystic fibrosis | |
| CN108088834B (zh) | 基于优化反向传播神经网络的包虫病血清拉曼光谱诊断仪 | |
| JP2003502661A (ja) | 多重検出システムおよび装置 | |
| Santos et al. | ATR-FTIR spectroscopy for virus identification: A powerful alternative | |
| US12082561B2 (en) | System and method for non-invasively determining egg properties | |
| US20110028808A1 (en) | Method and apparatus for examination of cancer, systemic lupus erythematosus (sle), or antiphospholipid antibody syndrome using near-infrared light | |
| Fufurin et al. | Numerical techniques for infrared spectra analysis of organic and inorganic volatile compounds for biomedical applications | |
| CN115735123A (zh) | 用于检测分析物的微电子传感器、使用微电子传感器的装置和方法 | |
| US11045111B1 (en) | Real time breath analyzer for detecting volatile organic compounds and identifying diseases or disorders | |
| CA3171027A1 (en) | Systems and methods for non-invasive determination of covid-19 coronavirus infection | |
| Dai et al. | Nondestructive detection for egg freshness based on hyperspectral scattering image combined with ensemble learning | |
| Bogomolov et al. | Synergy effect of combining fluorescence and mid infrared fiber spectroscopy for kidney tumor diagnostics | |
| US11740171B2 (en) | Open-ended hollow coaxial cable resonator sensor | |
| Siddiqui et al. | An approach to detect chronic obstructive pulmonary disease using UWB radar-based temporal and spectral features | |
| Raypah et al. | Near-infrared spectroscopy as a potential COVID-19 early detection method: A review and future perspective | |
| Zhang et al. | Performance of Classification Models of Toxins Based on Raman Spectroscopy Using Machine Learning Algorithms | |
| JPWO2007066589A1 (ja) | 近赤外分光を用いた生活習慣病に関する検査・診断法および装置 | |
| Kistenev et al. | Breathomics for lung cancer diagnosis | |
| Erukhimovitch et al. | Use of Fourier transform infrared microscopy<? xpp qa?> for the evaluation of drug efficiency |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220923 |
|
| EEER | Examination request |
Effective date: 20220923 |
|
| EEER | Examination request |
Effective date: 20220923 |